Vaccines for the elderly: current use and future challenges

Weinberger, Birgit

doi:10.1186/s12979-017-0107-2

Immunity & Ageing

Table 1 Vaccination recommendations for older adults in Europe and the US

From: Vaccines for the elderly: current use and future challenges

	Influenza^a	S. pneumoniae^b	Herpes zoster^d	Tetanus	Diphtheriaⁱ	Pertussis^j
Austria	all adults	> 50; PCV + PPV^c	> 50	every 5 years^e	every 5 years^e	every 5 years^e
Belgium	> 65	> 65; PCV + PPV^c		every 10 years	every 10 years	once^h
Bulgaria	> 65	–	–	every 10 years	every 10 years	–
Croatia	> 65	–		once at 60	–	–
Cyprus	> 65	> 65; PPV		every 10 years	every 10 years	–
Czech Rep.	all adults	> 65; PCV + PPV^c	> 50	every 10 years^f	–	once at 65
Denmark	> 65	> 65; PCV or PPV		–	–	–
Estonia	> 65	–		every 10 years	every 10 years	–
Finland	> 65	> 65; PCV or PPV		every 10 years	every 10 years	–
France	> 65	–	65-75	every 10 years^g	every 10 years^g	once^h
Germany	> 60	> 60; PPV		every 10 years	every 10 years	once^h
Greece	> 60	> 65; PCV	> 60	every 10 years	every 10 years	once^h
Hungary	> 60	> 50; PPV		–	–	–
Iceland	> 60	> 60; PPV		–	–	–
Ireland	> 65	> 65; PPV		–	–	–
Italy	> 65	> 65; PCV + PPV^c	> 65	every 10 years	every 10 years	every 10 years
Latvia	> 65	–		every 10 years	every 10 years	–
Liechtenstein	> 65	–		every 10 years^g	every 10 years^g	every 10 years^g
Lithuania	> 65	–		every 5-10 years	every 5-10 years	–
Luxembourg	> 65	> 60; PCV + PPV^c		every 10 years	every 10 years	every 10 years
Malta	all adults	> 65; PCV		–	–	–
Netherlands	> 60	–		–	–	–
Norway	> 65	> 65; PPV		–	–	–
Poland	all adults	> 50; PCV		once^h	once^h	–
Portugal	> 65	–		every 10 years^g	every 10 years^g	–
Romania	> 65	–		–	–	–
Slovakia	> 60	> 60; PCV		every 15 years	every 15 years	–
Slovenia	all adults	> 65;PCV or PPV		every 10 years	every 10 years	once^h
Spain	> 65	> 65; PPV		once at 65	once at 65	–
Sweden	–	> 65; PPV		every 20 years	every 20 years	–
UK	> 65	> 65; PPV	> 70	–	–	–
USA	all adults	> 65; PCV + PPV^c	> 60	every 10 years	every 10 years	once^h

Shown are recommendations for the general population for all countries listed by the European Centre for Disease Prevention and Control. Specific recommendations for risk groups (co-morbidities, health care personnel etc.) are available in most countries
^aannual vaccination, inactivated trivalent vaccine
^brecommendation for persons without prior vaccination against pneumococcal disease; no booster shots recommended for general population; recommendations may differ for persons with underlying medical conditions
^cone dose of PCV13 (pneumococcal conjugate vaccine) followed by 1 dose of PPV23 (pneumococcal polysaccharide vaccine)
^done dose, contraindicated in immunosuppressed patients (live vaccine)
^efor persons over 65 years; every 10 years for younger adults
^ffor persons over 65 years; every 10-15 years for younger adults
^gfor persons over 65 years; every 20 years for younger adults
^honce during adulthood
ⁱvaccine containing reduced diphtheria dose (d)
^jvaccine containing acellular pertussis antigens

Back to article page

ISSN: 1742-4933

Contact us

General enquiries: journalsubmissions@springernature.com